In oncology, an emerging paradigm emphasises molecularly targeted approaches for cancer prevention and therapy and the use of adjuvant chemotherapeutics to overcome cisplatin limitations. Owing to their safe use, some polyphenols, such as curcumin, modulate important pathways or molecular targets in cancers. This paper focuses on curcumin as an adjuvant molecule to cisplatin by analysing its potential implications on the molecular targets, signal transducer and activator of transcription 3 (STAT3) and NF-E2 p45-related factor 2 (Nrf-2), in tumour progression and cisplatin resistance in vitro and the adverse effect ototoxicity in vivo.

Fetoni, A. R., Paciello, F., Mezzogori, D., Rolesi, R., Eramo, S. L. M., Paludetti, G., Troiani, D., Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling, <<BRITISH JOURNAL OF CANCER>>, 2015; 113 (10): 1434-1444. [doi:10.1038/bjc.2015.359] [http://hdl.handle.net/10807/70604]

Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling

Fetoni, Anna Rita;Paciello, Fabiola;Mezzogori, Daniele;Rolesi, Rolando;Eramo, Sara Letizia Maria;Paludetti, Gaetano;Troiani, Diana
2015

Abstract

In oncology, an emerging paradigm emphasises molecularly targeted approaches for cancer prevention and therapy and the use of adjuvant chemotherapeutics to overcome cisplatin limitations. Owing to their safe use, some polyphenols, such as curcumin, modulate important pathways or molecular targets in cancers. This paper focuses on curcumin as an adjuvant molecule to cisplatin by analysing its potential implications on the molecular targets, signal transducer and activator of transcription 3 (STAT3) and NF-E2 p45-related factor 2 (Nrf-2), in tumour progression and cisplatin resistance in vitro and the adverse effect ototoxicity in vivo.
Inglese
Fetoni, A. R., Paciello, F., Mezzogori, D., Rolesi, R., Eramo, S. L. M., Paludetti, G., Troiani, D., Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling, <<BRITISH JOURNAL OF CANCER>>, 2015; 113 (10): 1434-1444. [doi:10.1038/bjc.2015.359] [http://hdl.handle.net/10807/70604]
File in questo prodotto:
File Dimensione Formato  
BJC 2015.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 3.04 MB
Formato Adobe PDF
3.04 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/70604
Citazioni
  • ???jsp.display-item.citation.pmc??? 38
  • Scopus 86
  • ???jsp.display-item.citation.isi??? 77
social impact